2012 Annual Meeting | Acute Encephalopathy

Date Saturday 03/23/13

Time 06:30 AM - 09:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Extended Seminar

Director(s) Michel T. Torbey, MD, MPH, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should understand the different causes of acute encephalopathy. They will be able to choose the appropriate diagnostic and therapeutic algorithm and implement that in their daily patient management routines.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic

Program Evaluations

Event Timeline
06:30 AM - 06:35 AM		Welcome and Introduction Michel T. Torbey, MD, MPH, F�鶹��ýӳ��
06:30 AM - 09:30 AM		Break
06:35 AM - 07:00 AM		Initial Workup and Differential Diagnosis Michel T. Torbey, MD, MPH, F�鶹��ýӳ��
07:00 AM - 08:00 AM		Toxic and Metabolic Encephalopathies Panayiotis N. Varelas, MD, PhD, F�鶹��ýӳ��
08:00 AM - 09:00 AM		Infectious and Inflammatory Encephalopathies Thomas P. Bleck, MD, F�鶹��ýӳ��
09:00 AM - 09:30 AM		Questions and Answers

Faculty Disclosures
Michel T. Torbey, MD, MPH, F�鶹��ýӳ��	Dr. Torbey has nothing to disclose.
Panayiotis N. Varelas, MD, PhD, F�鶹��ýӳ��	Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca -Alexion - Portola. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca- Alexion-Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Varelas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Giammarco, Mullins & Horton P.C. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Un of Michigan. The institution of Dr. Varelas has received research support from Marinus. The institution of Dr. Varelas has received research support from Bayer. Dr. Varelas has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Rep to the RUC meeting with �鶹��ýӳ��. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as a Speaker at the Annual Meeting with �鶹��ýӳ��. Dr. Varelas has a non-compensated relationship as a President - Past President with Neurocritical Care Society that is relevant to �鶹��ýӳ�� interests or activities.
Thomas P. Bleck, MD, F�鶹��ýӳ��	Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH.